<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05035134</url>
  </required_header>
  <id_info>
    <org_study_id>TDSJWKICHEX</org_study_id>
    <nct_id>NCT05035134</nct_id>
  </id_info>
  <brief_title>Application of Circulating Exosomes in Early Diagnosis and Prognosis Evaluation After Intracerebral Hemorrhage</brief_title>
  <official_title>Application of Circulating Exosomes in Early Diagnosis and Prognosis Evaluation After Intracerebral Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to observe the relationship between the changes of circulating&#xD;
      exosomes and the development and outcome of the disease in patients with intracerebral&#xD;
      hemorrhage, and to search for early serum markers and potential intervention targets for&#xD;
      disease monitoring in patients with intracerebral hemorrhage&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 12, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The type and content of circulating exosomes</measure>
    <time_frame>within 24 hours of ICH</time_frame>
    <description>After the exosomes were isolated, RNA sequencing and proteome sequencing were performed to identify the change of circulating exosomes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Rankin scale (mRS) scores</measure>
    <time_frame>from onset to three months or six months</time_frame>
    <description>mRS scores was divided into seven grades (0-6). The higher the score, the more severe the symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>through study completion，an average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>From hospitalization to discharge，up to one month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Intracerebral Hemorrhage；Circulating Exosomes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All of the ICH patients receiving treatment in Tangdu Hospital during 2021-2022&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. No systematic treatment was given before admission;&#xD;
&#xD;
          2. The patients were diagnosed with cerebral hemorrhage, and had imaging evidence;&#xD;
&#xD;
          3. The age was more than 18 years old;&#xD;
&#xD;
          4. The patient or family member agrees to sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Hematoma is caused by secondary factors (intracranial tumor, arteriovenous&#xD;
             malformation or aneurysm);&#xD;
&#xD;
          2. Bleeding into the ventricle;&#xD;
&#xD;
          3. Multiple cerebral hemorrhage;&#xD;
&#xD;
          4. The patient did not receive treatment in our hospital;&#xD;
&#xD;
          5. Severe disability, dementia, or organ dysfunction before onset&#xD;
&#xD;
          6. Coagulopathy or long-term use of anticoagulants&#xD;
&#xD;
          7. Hematoma affects brain stem&#xD;
&#xD;
          8. Subjects refused to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Qu, M.D, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Tang-Du Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xun Wu, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tang-Du Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xun Wu, M.D</last_name>
    <phone>86-15609261331</phone>
    <email>2645302700@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tandu Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xun Wu, M.D</last_name>
      <phone>86-15609261331</phone>
      <email>2645302700@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

